Reviewing U.S. Physical Therapy (USPH) & DCC (DCCPF)
U.S. Physical Therapy (NYSE: USPH) and DCC (OTCMKTS:DCCPF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.
This table compares U.S. Physical Therapy and DCC’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|U.S. Physical Therapy||5.38%||13.12%||6.38%|
This is a breakdown of current ratings and price targets for U.S. Physical Therapy and DCC, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|U.S. Physical Therapy||0||3||1||0||2.25|
U.S. Physical Therapy currently has a consensus target price of $77.00, indicating a potential downside of 15.34%. Given U.S. Physical Therapy’s higher possible upside, analysts clearly believe U.S. Physical Therapy is more favorable than DCC.
U.S. Physical Therapy pays an annual dividend of $0.92 per share and has a dividend yield of 1.0%. DCC does not pay a dividend. U.S. Physical Therapy pays out 44.2% of its earnings in the form of a dividend. U.S. Physical Therapy has raised its dividend for 7 consecutive years.
Valuation and Earnings
This table compares U.S. Physical Therapy and DCC’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|U.S. Physical Therapy||$414.05 million||2.76||$22.25 million||$2.08||43.73|
U.S. Physical Therapy has higher revenue and earnings than DCC.
Risk and Volatility
U.S. Physical Therapy has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, DCC has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500.
Insider and Institutional Ownership
96.5% of U.S. Physical Therapy shares are owned by institutional investors. 2.5% of U.S. Physical Therapy shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
U.S. Physical Therapy beats DCC on 10 of the 12 factors compared between the two stocks.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
DCC Company Profile
DCC plc provides sales, marketing, and business support services worldwide. The company's DCC Energy segment offers oil and liquefied petroleum gas products to commercial, retail, agricultural, industrial, marine, and other customers, as well as fuel cards. This segment serves approximately 1.4 million customers in approximately 9 countries. Its DCC Technology segment sells a range of computing products, including tablets, notebooks, and PC's; communications products, such as smartphones, feature phones, accessories, and unified communications; and servers and storage, audio visual products, printers, peripherals, networking and security products, cables and connectors, and consumables, as well as consumer technology products comprising gaming consoles, peripherals and software, wearable technology, consumer electronics, and accessories to retailers, etailers, and resellers. This segment also offers supply chain services. The company's DCC Healthcare segment sells, markets, and distributes a range of own and third party branded pharmaceuticals and medical devices to hospitals, pharmacies, GPs, and other healthcare providers; and outsourced product development, manufacturing, packing, and other services to the health and beauty brand owners. This segment provides generic pharmaceuticals, including solid dose, injectable, and inhaler products across a range of therapy areas, including oncology, beta lactam and other antibiotics, respiratory, pain management, hematology, anaesthesia, addiction, and emergency medicine; and medical devices and consumables in the areas of wound care, electrodes, diathermy, anaesthesia, endovascular, cardiology and IV access, minimally invasive surgery, and diagnostics. It also provides nutritional, beauty, and healthcare creams and liquids. DCC plc was founded in 1976 and is headquartered in Dublin, Ireland.
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.